178 related articles for article (PubMed ID: 874326)
21. Brief communication: technical modifications of the human agarose microdroplet leukocyte migration inhibition assay.
Weese JL; McCoy JL; Dean JH; Ortaldo JR; Burk KR; Herberman RB
J Immunol Methods; 1978; 24(3-4):363-70. PubMed ID: 722101
[TBL] [Abstract][Full Text] [Related]
22. Monocyte response receptors in BCG driven delayed type hypersensitivity to tuberculin.
Strapagiel D; Kasztalska K; Druszczyńska M; Kowalewicz-Kulbat M; Vrba A; Matusiak A; Chmiela M; Rudnicka W
Folia Histochem Cytobiol; 2008; 46(3):353-9. PubMed ID: 19056540
[TBL] [Abstract][Full Text] [Related]
23. Cell-mediated immune response to tuberculosis antigens: comparison of skin testing and measurement of in vitro gamma interferon production in whole-blood culture.
Katial RK; Hershey J; Purohit-Seth T; Belisle JT; Brennan PJ; Spencer JS; Engler RJ
Clin Diagn Lab Immunol; 2001 Mar; 8(2):339-45. PubMed ID: 11238218
[TBL] [Abstract][Full Text] [Related]
24. The agarose migration inhibition technique for in vitro demonstration of cell-mediated immunity in man. A review.
Clausen JE
Dan Med Bull; 1975 Jul; 22(5):181-94. PubMed ID: 126141
[No Abstract] [Full Text] [Related]
25. A comparison of the inhibition of leucocyte migration and monocyte spreading as in vitro assays for tuberculin hypersensitivity in man.
Silobrcić V; Sabioncello A; Mazuran R; Dekaris D; Kadrnka-Lovrencić M
Clin Exp Immunol; 1975 May; 20(2):239-47. PubMed ID: 813926
[TBL] [Abstract][Full Text] [Related]
26. Cellular and humoral immunity to purified protein derivative (PPD) in PPD skin reactive and nonreactive patients with pulmonary tuberculosis: comparative analysis of antigen-specific lymphocyte proliferation and IgG antibodies.
Boras Z; Juretić A; Rudolf M; Uzarević B; Trescec A
Croat Med J; 2002 Jun; 43(3):301-5. PubMed ID: 12035136
[TBL] [Abstract][Full Text] [Related]
27. Leukocyte migration inhibition by dental plaque antigens as indicated by the capillary tube and the agarose plate technique.
Budtz-Jörgensen E; Kelstrup J; Budtz-Jörgensen A
J Periodontal Res; 1976 Apr; 11(2):86-95. PubMed ID: 132521
[No Abstract] [Full Text] [Related]
28. [Studies of an assay system for dialyzable leukocyte extracts (DLE)--influence of DLE on leukocyte migration inhibition test by HBsAg].
Hashimoto Y; Sekiguchi S
Hokkaido Igaku Zasshi; 1985 Sep; 60(5):763-8. PubMed ID: 3908264
[TBL] [Abstract][Full Text] [Related]
29. [Examination of cell-mediated immunity using the leukocyte migration inhibition test in agarose].
Zimmermann S; Felber F
Z Gesamte Inn Med; 1977 Feb; 32(4):54-5. PubMed ID: 855396
[TBL] [Abstract][Full Text] [Related]
30. Dose-response relationship in the migration inhibition test using peritoneal exudate cells and blood leucocytes of tuberculin sensitive guinea pigs.
Sabioncello A; Dekaris D
Biomedicine; 1977 Dec; 26(6):399-403. PubMed ID: 606302
[TBL] [Abstract][Full Text] [Related]
31. Lack of leukocyte migration inhibition by hepatitis B antigen and normal nonspecific immunoreactivity in asymptomatic carriers.
Desaules M; Frei PC; Libanska J; Wuilleret B
J Infect Dis; 1976 Nov; 134(5):505-9. PubMed ID: 993619
[TBL] [Abstract][Full Text] [Related]
32. Mononuclear cells migration inhibition and delayed hypersensitivity in man.
Ng RP; Alexopoulos CG
J Immunol Methods; 1976; 11(1):1-6. PubMed ID: 1270810
[TBL] [Abstract][Full Text] [Related]
33. Species-restricted effects of human and mouse lymphokines on macrophages.
Tagliabue A; Mantovani A; Boraschi D; Herberman RB
Eur J Immunol; 1980 Jul; 10(7):542-6. PubMed ID: 6157542
[TBL] [Abstract][Full Text] [Related]
34. Serum modulation of in vitro cellular immune reactivity to Epstein-Barr virus-associated antigen.
Holt PG; Fimmel PJ; Roberts LM; Keast D
Med Microbiol Immunol; 1976 Dec; 162(3-4):209-16. PubMed ID: 187919
[TBL] [Abstract][Full Text] [Related]
35. Decreased correlation between the agarose leukocyte migration inhibition assay and delayed cutaneous hypersensitivity response to purified protein derivative in cancer patients.
Chee DO; Holmes EC; Morton DL
J Natl Cancer Inst; 1978 Apr; 60(4):769-72. PubMed ID: 633387
[No Abstract] [Full Text] [Related]
36. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
[TBL] [Abstract][Full Text] [Related]
37. Cell-mediated immunity against digestive organ cancers : leucocyte migration inhibitory factor activity as an immunological parameter.
Hamasaki K
Acta Med Okayama; 1977 Jun; 31(3):147-59. PubMed ID: 144415
[TBL] [Abstract][Full Text] [Related]
38. Cell-mediated immunity to viruses measured by the indirect agarose technique of leukocyte migration inhibition.
Anders EM; Natvig JB
Cell Immunol; 1976 Dec; 27(2):214-29. PubMed ID: 795549
[No Abstract] [Full Text] [Related]
39. Migration inhibition of T lymphocytes from human peripheral blood by specific antigen and lymphokines.
Kowalczyk D; Zembala M
Clin Exp Immunol; 1978 May; 32(2):333-8. PubMed ID: 307468
[TBL] [Abstract][Full Text] [Related]
40. In vitro correlates of delayed hypersensitivity in man: ambiguity of polymorphonuclear neutrophils as indicator cells in leukocyte migration test.
Senyk G; Hadley WK
Infect Immun; 1973 Sep; 8(3):370-80. PubMed ID: 4581009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
